Globeways Holdings Ltd

CIK 00016007695 companiesROAD TOWN, TORTOLA, D8

SEC Profile

Transactions

Companies

Filings

CIK

0001600769

Recent Transactions

50 trades

Conversion
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2021-01-12+1,136,525→ 1,136,525 total
Conversion
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2021-01-12+455,338→ 455,338 total
Conversion
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2021-01-12+2,912,345→ 2,912,345 total
Conversion
Cullinan Therapeutics, Inc.$CGEM
Series Seed Convertible Preferred Stock
2021-01-12−8,000,000→ 0 total
Conversion
Cullinan Therapeutics, Inc.$CGEM
Series B Convertible Preferred Stock
2021-01-12−3,205,128→ 0 total
Conversion
Cullinan Therapeutics, Inc.$CGEM
Series C Convertible Preferred Stock
2021-01-12−503,988→ 0 total
Conversion
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2021-01-12+639,295→ 639,295 total
Conversion
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2021-01-12+71,599→ 526,937 total
Conversion
Cullinan Therapeutics, Inc.$CGEM
Series A Convertible Preferred Stock
2021-01-12−20,500,000→ 0 total
Conversion
Cullinan Therapeutics, Inc.$CGEM
Series A Convertible Preferred Stock
2021-01-12−4,500,000→ 0 total
Conversion
Cullinan Therapeutics, Inc.$CGEM
Series C Convertible Preferred Stock
2021-01-12−1,511,966→ 0 total
Conversion
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2021-01-12+182,135→ 182,135 total
Conversion
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2021-01-12+143,198→ 325,333 total
Conversion
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2021-01-12+71,599→ 71,599 total
Conversion
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2021-01-12+214,798→ 214,798 total
Purchase
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2021-01-12$21.00/sh+95,238→ 622,175 total
Conversion
Cullinan Therapeutics, Inc.$CGEM
Series C Convertible Preferred Stock
2021-01-12−1,007,977→ 0 total
Conversion
Cullinan Therapeutics, Inc.$CGEM
Series C Convertible Preferred Stock
2021-01-12−503,988→ 0 total
Purchase
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2021-01-12$21.00/sh+104,762→ 104,762 total
Conversion
Cullinan Therapeutics, Inc.$CGEM
Series B Convertible Preferred Stock
2021-01-12−1,282,051→ 0 total
Other
TCR2 THERAPEUTICS INC.
Common Stock
2019-12-20−13,847→ 161,024 total
Other
TCR2 THERAPEUTICS INC.
Common Stock
2019-12-20−586,153→ 713,723 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2019-12-19$16.47/sh−35,323→ 155,986 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2019-12-19$16.47/sh−6,642→ 82,575 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2019-12-18$17.01/sh−2,433→ 191,309 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2019-12-18$17.01/sh−458→ 89,217 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2019-12-11$17.65/sh−4,153→ 1,299,876 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2019-12-11$17.65/sh−1,381→ 432,319 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2019-12-11$17.65/sh−1,155→ 361,665 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2019-12-11$17.65/sh−1,054→ 330,238 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2019-12-10$17.62/sh−7,741→ 331,292 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2019-12-10$17.62/sh−8,479→ 362,820 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2019-12-10$17.62/sh−10,135→ 433,700 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2019-12-10$17.62/sh−30,475→ 1,304,029 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2019-12-09$17.65/sh−75,067→ 1,334,504 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2019-12-09$17.65/sh−19,070→ 339,033 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2019-12-09$17.65/sh−20,886→ 371,299 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2019-12-09$17.65/sh−24,966→ 443,835 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2019-10-22$15.16/sh−580→ 392,185 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2019-10-22$15.16/sh−693→ 392,185 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2019-10-22$15.16/sh−2,085→ 1,409,571 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2019-10-22$15.16/sh−530→ 358,103 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2019-09-23$17.31/sh−351→ 89,675 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2019-09-23$17.31/sh−1,835→ 469,464 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2019-09-23$17.31/sh−5,516→ 1,411,656 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2019-09-23$17.31/sh−1,401→ 358,633 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2019-09-23$17.31/sh−683→ 174,871 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2019-09-23$17.31/sh−1,535→ 392,765 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2019-09-20$17.94/sh−197,343→ 1,417,172 total
Sale
TCR2 THERAPEUTICS INC.
Common Stock
2019-09-20$17.94/sh−54,907→ 394,300 total

Companies

Recent Filings

4
Jovan-Embiricos Morana
Jan 14, 2021

Address

3RD FLOOR, GENEVE PLACE, WATERFRONT DR. PO BOX 3175

ROAD TOWN, TORTOLA, D8

View on SEC.gov